Ebola: What Should We Do Now?


Dr. Larry Brilliant, our senior advisor and former president who was a key player in smallpox eradication, writes in the Wall Street Journal about what we should do about Ebola and future infectious disease threats. Better detection, new diagnostics, applying new technologies to proven practices like containment, and better cross-border regional collaboration are all important areas where progress in being made, but needs to be accelerated. Read the article here.